H.R. 1060 119th Congress House

Modern Authentication of Pharmaceuticals Act of 2025

Official title: To amend the Federal Food, Drug, and Cosmetic Act to modernize the methods of authenticating controlled substances in the pharmaceutical distribution supply chain, and for other purposes.

Introduced: February 6, 2025 Introduced by: Donald G. Davis Democratic · North Carolina See on congress.gov

Health Drug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesPrescription drugsSupply chain

Everywhere this bill has been 3 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Feb 6, 2025

Referred to the House Committee on Energy and Commerce.

Feb 6, 2025

Sponsor introductory remarks on measure. (CR H519)

Feb 6, 2025

Introduced in House

Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

What's happening now February 6, 2025

Referred to the House Committee on Energy and Commerce.

Plain-English summary Congressional Research Service

Modern Authentication of Pharmaceuticals Act of 2025

This bill requires each dose of a pharmaceutical product that is a controlled substance and that is taken orally in solid form (i.e., pills) to include a physical chemical identifier. (Physical chemical identifiers are substances that possess a unique physical or chemical property, such as inks, pigments, flavors, and molecular taggants, that unequivocally identify and authenticate a drug or dosage.) Under the bill, physical chemical identifiers must be included in or on the product and must be machine readable.

The bill applies to products manufactured beginning five years after the bill's enactment.

Bill text 1 version

Introduced in House Formatted Text PDF Formatted XML

Source documents hosted by congress.gov.

Committees of jurisdiction 1

Energy and Commerce Committee
House of Representatives

Cosponsors 3

Fitzpatrick, Brian K.

Pennsylvania · Mar 11, 2025

Bacon, Don

Nebraska · Feb 6, 2025

Rutherford, John H.

Florida · Feb 6, 2025

Cite this page click to expand

APA

U.S. Congress. (2026). H.R. 1060: Modern Authentication of Pharmaceuticals Act of 2025. 119th Congress. Open America. https://openamerica.io/bill/119-HR-1060/

MLA

"H.R. 1060: Modern Authentication of Pharmaceuticals Act of 2025." 119th Congress, 2026, Open America, https://openamerica.io/bill/119-HR-1060/.

Bluebook (legal)

H.R. 1060, 119th Cong. (2026), https://openamerica.io/bill/119-HR-1060/.

Markdown link

[H.R. 1060: Modern Authentication of Pharmaceuticals Act of 2025](https://openamerica.io/bill/119-HR-1060/)